10:12 AM EST - Concordia International Corp. : Entered into a three-year, co-promotion agreement with RedHill Biopharma Ltd., through which the companies expect to expand sales of Donnatal®, Concordia's product used in the treatment of irritable bowel syndrome. Concordia International Corp.
shares T.CXR are trading up $0.18 at $3.03.
